Heart attack test gets a Tune-Up: new method aims to cut false positives
NCT ID NCT04465591
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study is testing a new way to analyze blood samples to see if it can better tell when someone is having a heart attack. Current tests can be misleading in patients with other conditions like kidney failure. Researchers will look at how troponin T, a protein released during heart injury, breaks down into fragments. The goal is to see if the fragmentation pattern can help doctors make a more accurate diagnosis. The study will enroll 1,500 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Turku University Hospital, Heart Center
RECRUITINGTurku, Southwest Finland, 20521, Finland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
University Hospital Zurich
ENROLLING_BY_INVITATIONZurich, 8091 Zurich, Switzerland
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
troponin T fragmentation test (blood test)
What this could lead to
If successful, this test could help doctors more accurately diagnose heart attacks and avoid false alarms from other conditions like kidney disease.
What could go wrong
This is an early observational study, so the test may not prove reliable enough for routine use. It is not a treatment and will not directly improve patient outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.